InVitro International, Inc. IVRO

IVRO Company Overview

InVitro International, Inc. (OTC Pink: IVRO) is a U.S.-based company historically focused on alternative testing technologies and services intended to reduce or replace the use of animal testing in toxicology and product safety assessment. Public disclosures and historical filings indicate that the company operated within the broader biotechnology, life sciences, and in vitro testing industries, with activities centered on commercializing non-animal testing methods for cosmetics, chemicals, and related consumer products.

The company’s historical business model included laboratory testing services, licensing opportunities, and the development or distribution of in vitro toxicology technologies. Available public information suggests that InVitro International sought to position itself within the regulatory and commercial shift toward cruelty-free and scientifically validated alternative testing methods. However, recent publicly available operational and financial disclosures appear limited, and certain details regarding current commercial scale, active revenue streams, and present-day operating status are inconclusive based on available public sources.